SANUWAVE, Inc. Receives U.S. Patent for New Type of Applicators Used for Shock Wave Technology

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ALPHARETTA, Ga., Oct. 17, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) has received a patent issued by the U.S. Patent and Trademark Office entitled “Extracorporeal Shock Wave Device.” The claims of the patent (patent number 8,556,813) relate to a new extracorporeal applicator, which creates significant advantages for certain applications. The patent has a term extending to April 2031.

Help employers find you! Check out all the jobs and post your resume.